Sign up with

Already have an account? Log in here

Need some help?
Talk to us at +91 7670800001

Access Strategy Manager at Merck Healthcare Vietnam Ltd., Vietnam

Ho Chi Minh City, , Vietnam -

Full Time

Start Date

Immediate

Expiry Date

10 Jan, 26

Salary

0.0

Posted On

12 Oct, 25

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Access Strategy, Healthcare Systems, Policy Tracking, Stakeholder Engagement, Evidence-Based Data, Cost-Effectiveness, Patient Assistance Program, Pricing Strategy, National Reimbursement Drug List, National Centralized Tender, Market Demand Analysis, Supply Chain Management, Strategic Thinking, Customer Orientation, Multinational Experience, English Proficiency

Industry

Pharmaceutical Manufacturing

Description

Report to: Head of Market Access and Pricing Base in: Hanoi Your roles: National Reimbursement Drug List (NRDL): Convince Health Authorities to include company products in the NRDL by presenting robust, evidence-based data on their efficacy and cost-effectiveness. National Centralized Tender in National Centralized Procurement Center (NCPC): Support the Distributor for a securing an appropriate quota plan for the market demand, good price approach and a securing supply plan. PAP (Patient Assistant program): Design a program to provide support to patients who may have difficulty accessing medications or healthcare services. Policy (related to NRDL, Pricing, Drug Procurement, Orphan drugs): Keep track of relevant policies to ensure the company's actions are well informed ahead & be compliant. Who You Are: Over 8 years of experience in multinational pharmaceutical companies, focusing on Access area (NRDL, PAP, Pricing, Policy). In-depth understanding of healthcare systems and relevant policies. Strategic thinker with a customer-oriented mindset, effectively engaging both internal and external stakeholders. Proficient in verbal and written English at an upper-intermediate level or higher.

Responsibilities

The Access Strategy Manager will work to convince health authorities to include company products in the National Reimbursement Drug List by presenting evidence-based data. Additionally, they will support distributors in securing appropriate quota plans and design patient assistance programs to help patients access medications.